A. Bianco

M. Salvatore, G. Esposito, A. Bianco, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Ornithine decarboxylase and diamine oxidase in human colon carcinoma cell line CaCo-2 in culture.

P. Tagliaferri, S. Pignata, B. Daniele, 1989, Gastroenterology.

Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma

M. Salvatore, G. Esposito, A. Bianco, 2004, European Journal of Nuclear Medicine.

The role of autophagy in neoplastic cell response to oncolytic viruses ”

Coordinator, G. Viglietto, P. Macchia, 2009 .

Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer

A. Rossi, C. Gridelli, A. Bianco, 1996, Cancer Chemotherapy and Pharmacology.

Is There a Standard Chemotherapeutic Regimen for Hormone-Refractory Prostate Cancer? Present and Future Approaches in the Management of the Disease

R. Autorino, A. Giordano, R. Bianco, 2003, Tumori.

Gonadal function after multimodality treatment in men with testicular germ cell cancer.

A. Bianco, G. Lombardi, G. Palmieri, 1996, European journal of endocrinology.

Gene expression profile analysis of pituitary adenomas developed by HMGA transgenic mice ”

J. Herman, I. Pastan, M. Gottesman, 2007 .

p53 Expression is Decreased in Primary Breast Carcinomas with Microsatellite Instability

S. Cocozza, A. Bianco, M. Di Maio, 2002, Breast Cancer Research and Treatment.

Reversible heart failure in a non-Hodgkin lymphoma patient being treated with alpha-interferon

G. Costantino, A. Bianco, G. Simone, 1988 .

Salvage chemotherapy for non Hodgkin's lymphoma of unfavourable histology with a combination of ccnu and vinblastine

C. Gridelli, F. Caponigro, A. Bianco, 1990, Hematological oncology.

Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer-and lymphokine-activated-killer-mediated cytotoxicity

P. Tagliaferri, M. Caraglia, N. Normanno, 2005, Cancer Immunology and Immunotherapy.

Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications

P. Tagliaferri, M. Caraglia, A. Bianco, 1998, Cancer Immunology, Immunotherapy.

Hypothalamic-Pituitary-Ovarian Axis in Women with Operable Breast Cancer Treated with Adjuvant CMF and Tamoxifen

A. Bianco, S. de Placido, S. Fasano, 1986, Tumori.

Cell kinetics and polyamine enzymes in the intestinal mucosa of rats with azoxymethane induced tumours.

S. Pignata, B. Daniele, G. Esposito, 1994, International journal of experimental pathology.

Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the β1 integrin profile of cultured human tumor cells

P. Tagliaferri, M. Caraglia, G. Marone, 1995, Anti-cancer drugs.

Goserelin depot in the treatment of premenopausal advanced breast cancer.

R. Blamey, M. Namer, W. Jonat, 1992, European journal of cancer.

High cell kinetics is associated with amplification of the int‐2, bcl‐1, myc and erbB‐2 proto‐oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers

P. Delrio, R. Mariani-Costantini, L. Ottini, 1995, International journal of cancer.

Desferioxamine increases iron depletion and apoptosis induced by ara‐C of human myeloid leukaemic cells

A. Abbruzzese, P. Tagliaferri, M. Caraglia, 1998, British journal of haematology.

Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone.

M. Salvatore, A. Colao, A. Colao, 1997, The New England journal of medicine.

Ultra-Low-Dose Interleukin-2 in Unresectable Hepatocellular Carcinoma

E. Biondi, A. Bianco, G. Palmieri, 2002, American journal of clinical oncology.

Cytosine arabinoside (Ara‐C) plus alpha‐interferon (αIFN) determine prolonged complete remissions in patients with aggressive non‐Hodgkin's lymphoma partially responsive to first‐line doxorubicin‐containing regimens

M. Caraglia, A. Bianco, A. Morabito, 1994, British journal of haematology.

Of course, since we have few data on antihypertensive treatment, this mechanism is speculative.

L. Ferrucci, J. Cerhan, M. Pahor, 1996 .

Induction of resistance against the transplantation of leukemias induced by Rauscher virus.

A. Goldin, A. Bianco, J. Glynn, 1966, Cancer research.

Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial.

R. Autorino, A. Bianco, G. Di Lorenzo, 2005, The Lancet. Oncology.

Doctorate Program in Molecular Oncology and Endocrinology

J. Herman, I. Pastan, M. Gottesman, 2006 .

Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.

G. Argenziano, G. Fabbrocini, G. de Rosa, 2005, Human pathology.

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

G. Fontanini, G. Tortora, D. Raben, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.

A. Bianco, G. Clack, S. Duffy, 2005, Human reproduction.

Microsatellite instability and pathological aspects of breast cancer

P. Delrio, R. Mariani-Costantini, L. Frati, 1995, International journal of cancer.

Prospective validation of the CLIP score, a new prognostic system for cirrhotic patients with hepatocellular carcinoma (RE: Hepatology 2000, 32/3: 679-80)

Bellia Mario, F. Izzo, P. Vallone, 2000 .

Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer

A. Bianco, C. Gallo, F. Perrone, 1990, Breast Cancer Research and Treatment.

Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.

J. Cuzick, J. Forbes, A. Buzdar, 2008, The Lancet. Oncology.

A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer

G. Tortora, F. Ciardiello, G. Arpino, 2005, Clinical Cancer Research.

Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).

A. Rossi, C. Gridelli, A. Russo, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Plasma postheparin diamine oxidase in patients with small intestinal lymphoma

S. Pignata, B. Daniele, A. Bianco, 1991, Cancer.

Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer

S. Iacobelli, C. Gridelli, A. Russo, 2004, Cancer Chemotherapy and Pharmacology.

Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer

A. Rossi, C. Gridelli, A. Bianco, 2004, Cancer Chemotherapy and Pharmacology.

The prognostic value of lymphatic and blood vessel invasion in operable breast cancer

A. Bianco, C. Gallo, A. Morabito, 1995, Cancer.

ADJUVANT THERAPY WITH TAMOXIFEN IN OPERABLE BREAST CANCER 10 year results of the Naples (GUN) study

A. Bianco, C. Gallo, G. Petrella, 1988, The Lancet.

Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.

G. Fontanini, G. Tortora, F. Ciardiello, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Antitumor Effects of ZD 6474 , a Small Molecule Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor , with Additional Activity against Epidermal Growth Factor Receptor Tyrosine Kinase 1

G. Fontanini, G. Tortora, F. Ciardiello, 2003 .

An Unusual Case of Primary Hormone-Secreting Germ Cell Tumor of the Retroperitoneum

F. Caponigro, A. Bianco, V. Montesarchio, 1987, Tumori.

Complete Regression of Laryngeal Involvement by Classic Kaposi's Sarcoma with Low-Dose Alpha-2b Interferon

C. Gridelli, A. Bianco, G. Palmieri, 1990, Tumori.

Role of somatostatin analogue-based therapy in unresponsive malignant thymomas.

M. Salvatore, A. Bianco, G. Lombardi, 1999, Annals medicus.

Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation.

P. Tagliaferri, M. Caraglia, M. Marinetti, 1997, Immunology letters.

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials.

C. Criscitiello, A. Giordano, A. Bianco, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second-line chemotherapy of advanced colorectal cancer with sequential high-dose methotrexate and 5-fluorouracil.

C. Gridelli, F. Caponigro, A. Bianco, 1991, Journal of chemotherapy.

Prognostic Factors in Human Colorectal Cancer

G. Tortora, F. Ciardiello, A. Bianco, 1997, Tumori.

BRCA1 and BRCA2 mutations in central and southern Italian patients

F. Guadagni, S. Carlini, R. Mariani-Costantini, 2000, Breast Cancer Research.

AMeta-Analysis on the Interaction between HER-2 Expression and Response to EndocrineTreatment in Advanced Breast Cancer

F. Ciardiello, G. Arpino, A. Bianco, 2005 .

Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.

S. Pepe, A. Bianco, C. Gallo, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

α‐interferon potentiates epidermal growth factor receptor‐mediated effects on human epidermoid carcinoma KB cells

P. Tagliaferri, M. Caraglia, F. Ciardiello, 1995 .

Intensive Alternating Combination Chemotherapy and High Dose Chest Radiotherapy in Small Cell Lung Cancer

C. Gridelli, A. Bianco, A. Contegiacomo, 1991, Tumori.

A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer

A. Bianco, D. Giannarelli, S. Fazio, 1989, Cancer.

A Phase I Study of Paclitaxel and Epirubicin, without and with Filgrastim, for the Treatment of Platinum-Resistant Advanced Ovarian Cancer

S. Pignata, A. Bianco, A. Morabito, 1999, Oncology.

Endocannabinoids as emerging suppressors of angiogenesis and breast tumor growth and metastatic spreading ”

J. Herman, I. Pastan, M. Gottesman, 2008 .

Chemotherapy with Mitomycin C and Vinblastine in Pretreated Metastatic Breast Cancer

C. Gridelli, A. Bianco, F. Nuzzo, 1993, Tumori.

Mitomycin C and Vindesine: An Ineffective Combination Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

A. Rossi, C. Gridelli, A. Bianco, 1992, Tumori.

Alpha-interferon induces depletion of intracellular iron content and upregulation of functional transferrin receptors on human epidermoid cancer KB cells.

P. Tagliaferri, M. Caraglia, V. Coppola, 1994, Biochemical and Biophysical Research Communications - BBRC.

Interferon alpha-2b at low doses as long-term antiangiogenic treatment of a metastatic intracranial hemangioendothelioma: a case report.

A. Bianco, G. Palmieri, L. Montella, 2000, Oncology reports.

Partial Response of Metastatic Hepatocellular Carcinoma after Treatment with Thymostimulin

C. Gridelli, F. Caponigro, A. Bianco, 1990, Tumori.

Ovarian luteinized thecoma with sclerosing peritonitis in an adult woman treated with leuprolide and toremifene in complete remission at 5 years.

G. de Rosa, S. Staibano, A. Bianco, 2005, Gynecologic oncology.

Contemporary Chemotherapy and Radiotherapy for Inguinal Metastases of Carcinoma of the Penis: A Case Report

C. Gridelli, A. Bianco, G. Palmieri, 1988, Tumori.

Serum‐properdin levels in patients with hodgkin's disease and carcinoma

A. Bianco, A. Levy, A. Rottino, 1957 .

Salvage Chemotherapy with Ccnu and Methotrexate for Small Cell Lung Cancer Resistant to Cav/Pe Alternating Chemotherapy

C. Gridelli, A. Bianco, F. Perrone, 1991, Tumori.

The First Breast Cancer Screening Program in Southern Italy: Preliminary Results from Three Municipalities of the Naples Province

P. Delrio, A. Sodano, A. Bianco, 1995, Tumori.

Tamoxifen in operable breast cancer

A. Bianco, 1989 .

Microsatellite instability is correlated with lymph node-positive breast cancer.

R. Mariani-Costantini, L. Ottini, L. Frati, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cell Kinetics and Tumor-Associated Antigen Expression in Human Mammary Carcinomas

L. Frati, R. Muraro, P. Battista, 1991, The International journal of biological markers.

Gefitinib and Radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck ”

J. Herman, I. Pastan, M. Gottesman, 2008 .

External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life.

R. Autorino, D. Raben, F. Ciardiello, 2003, Oncology reports.

Survival data relating to the use of goserelin depot in the treatment of premenopausal advanced breast cancer.

R. Blamey, W. Jonat, M. Kaufmann, 1993, European journal of cancer.

Ondansetron in the prophylaxis of nausea and vomiting induced by carboplatin combination chemotherapy.

C. Gridelli, A. Bianco, G. Airoma, 1993, European journal of cancer.

Low-dose recombinant IL-2 induces psychological changes: monitoring by Minnesota Multiphasic Personality Inventory (MMPI).

A. Abbruzzese, P. Tagliaferri, M. Caraglia, 2002, Anticancer research.

TAG-72 expression and clinical outcome in primary breast cancer.

R. Mariani-Costantini, R. Muraro, A. Bianco, 1999, Oncology reports.

Control of breast cancer cell growth by adipocyte-released factors ”

G. Viglietto, P. Macchia, A. Rosato, 2009 .

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

Bingshu E. Chen, R. Gray, P. Lønning, 2023, The Lancet.

Docetaxel in adjuvant therapy of breast cancer : results of the TAXIT 216 multicenter phase III trial ”

J. Herman, I. Pastan, M. Gottesman, 2008 .

Clinical trial with 5-fluorouracil and leucovorin.

C. Gridelli, A. Bianco, M. Balestrino, 1990, Journal of chemotherapy.

Structure-activity relationship, physicochemical and pharmacokinetic properties of AZD2171: A highly potent inhibitor of VEGF receptor tyrosine kinases

G. Tortora, F. Ciardiello, T. Troiani, 2004 .

Peritoneoscopy in chronic hepatitis. A retrospective evaluation of its role in the management of the asymptomatic patient.

A. Bianco, G. Budillon, G. Mazzacca, 1980, The American journal of gastroenterology.

Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapy.

P. Tagliaferri, M. Caraglia, V. Zagonel, 1994, Anti-cancer drugs.

Nuclear DNA content‐derived parameters correlated with heterogeneous expression of p53 and bcl‐2 proteins in clear cell renal carcinomas

G. de Rosa, S. Staibano, S. Pepe, 2000, Cancer.

Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma

Bernardino, A. Giorgio, A. Iannelli, 2000, Hepatology.

Transmembrane ion flux modifiers verapamil and ouabain modulate cytotoxic effects of extracellular ATP on human tumor-cells in-vitro.

P. Tagliaferri, M. Caraglia, M. Marinetti, 1993, International journal of oncology.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Irradiation of the hypothalamic–hypophyseal area induces complete regression of mucocutaneous lesions in disseminated histiocytosis X

C. Gridelli, A. Bianco, A. Bianco, 1989, Cancer.

Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma.

A. Abbruzzese, P. Tagliaferri, M. Caraglia, 2000, The Journal of clinical endocrinology and metabolism.

ROLE OF ADENOSINE 5' TRIPHOSPHATASE IN LYMPHOKINE ACTIVATED (LAK) KILLING OF HUMAN TUMOR CELLS

P. Tagliaferri, M. Caraglia, M. Marinetti, 1995 .

Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study

V. Adamo, S. Palazzo, C. Ficorella, 2005, British Journal of Cancer.

Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?

A. Bianco, A. Bianco, C. Gallo, 1996, European journal of cancer.